UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SP0166 All you need to know about kidney disease in antiphospholipid syndrome

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.44

Tektonidou, M.

2018

Volltextzugriff (PDF)

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

Lupus, 2011-02, Vol.20 (2), p.206-218

2011

Volltextzugriff (PDF)

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.476-485

2017

Volltextzugriff (PDF)

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

Annals of the Rheumatic Diseases, 2010-12, Vol.69 (12), p.2074-2082

2010

Volltextzugriff (PDF)

Identification and treatment of APS renal involvement

Lupus, 2014-10, Vol.23 (12), p.1276-1278

Tektonidou, MG

2014

Volltextzugriff (PDF)

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Arthritis research & therapy, 2020-03, Vol.22 (1), p.56-8, Article 56

2020

Volltextzugriff (PDF)

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1159-1161

2004

Volltextzugriff (PDF)

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Lupus, 2018-03, Vol.27 (3), p.399-406

2018

Volltextzugriff (PDF)

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus

Lupus, 2018-04, Vol.27 (4), p.564-571

2018

Volltextzugriff (PDF)

Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019)

Clinical and experimental rheumatology, 2023-10

2023

Volltextzugriff (PDF)

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

Lupus, 2011-02, Vol.20 (2), p.174-181

2011

Volltextzugriff (PDF)

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

Lupus, 2011-02, Vol.20 (2), p.165-173

2011

Volltextzugriff (PDF)

FRI0314 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Clinical Database and Repository Analysis: The Impact of Systemic Lupus Erythematosus on The Clinical Phenotype of Antiphospholipid Antibody-Positive Patients

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.548-549

2016

Volltextzugriff (PDF)

FRI0285 Detection of oligoclonal b-cell populations by spectratyping analysis in the renal tissue of patients with active lupus nephritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.680

2018

Volltextzugriff (PDF)

MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab

Lupus, 2010-09, Vol.19 (10), p.1243-1245

Tektonidou, MG

2010

Volltextzugriff (PDF)

Comparison of evidence of treatment effects in randomized and nonrandomized studies

JAMA : the journal of the American Medical Association, 2001-08, Vol.286 (7), p.821

2001

Volltextzugriff (PDF)

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study

British journal of rheumatology, 2003-05, Vol.42 (5), p.645-651

2003

Volltextzugriff (PDF)

THU0102 High rates of residual disease activity despite current therapies in a real life rheumatoid arthritiscohort: data from 1096 patients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.272

2018

Volltextzugriff (PDF)

Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial

Nephrology, dialysis, transplantation, 2012-05, Vol.27 (5), p.1924-1930

2012

Volltextzugriff (PDF)

FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.692

2018

Volltextzugriff (PDF)

POS1022 LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC)-FRAILTY INDEX (SLICC-FI) MAY SERVE AS A VALUABLE TOOL FOR EARLY DETECTION OF SUBCLINICAL CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.994-994

2024

Volltextzugriff (PDF)

POS1137 PREDICTORS OF ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS DURING A 10-YEAR FOLLOW-UP IN SYSTEMIC LUPUS ERYTHEMATOSUS VERSUS HEALTHY CONTROLS: THE IMPACT OF SUSTAINED REMISSION, CARDIOVASCULAR RISK FACTOR TARGET ATTAINMENT AND ANTIPHOSPHOLIPID SYNDROME

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1008-1008

2024

Volltextzugriff (PDF)

THU0260 Circulating levels of tnf-like cytokine 1A (TL1A) are increased in patients with ankylosing spondylitis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.242-242

2013

Volltextzugriff (PDF)

POS0172 ARTERIAL STIFFNESS IN ANTIPHOSPHOLIPID SYNDROME: COMPARISON WITH DIABETES MELLITUS AND HEALTHY CONTROLS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.309-310

2023

Volltextzugriff (PDF)

Microwave Radiometry for the Diagnosis and Monitoring of Inflammatory Arthritis

Diagnostics (Basel), 2023-02, Vol.13 (4), p.609

2023

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(98)
Science & Technology
(98)
Humans
(81)
Rheumatology
(79)
Female
(53)
Adult
(40)
Male
(38)
Antiphospholipid Syndrome
(37)
Lupus
(36)
Patients
(33)
Systemic Lupus Erythematosus
(33)
Antiphospholipid Syndrome - Complications
(25)
Autoimmune Diseases
(24)
Middle Aged
(23)
Antiphospholipid Antibodies
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Pregnancy
(16)
Rheumatoid Arthritis
(16)
Risk Factors
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(9)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

SP0166 All you need to know about kidney disease in antiphospholipid syndrome

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

Identification and treatment of APS renal involvement

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus

Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019)

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

FRI0314 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Clinical Database and Repository Analysis: The Impact of Systemic Lupus Erythematosus on The Clinical Phenotype of Antiphospholipid Antibody-Positive Patients

FRI0285 Detection of oligoclonal b-cell populations by spectratyping analysis in the renal tissue of patients with active lupus nephritis

MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab

Comparison of evidence of treatment effects in randomized and nonrandomized studies

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study

THU0102 High rates of residual disease activity despite current therapies in a real life rheumatoid arthritiscohort: data from 1096 patients

Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial

FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study

POS1022 LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC)-FRAILTY INDEX (SLICC-FI) MAY SERVE AS A VALUABLE TOOL FOR EARLY DETECTION OF SUBCLINICAL CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

POS1137 PREDICTORS OF ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS DURING A 10-YEAR FOLLOW-UP IN SYSTEMIC LUPUS ERYTHEMATOSUS VERSUS HEALTHY CONTROLS: THE IMPACT OF SUSTAINED REMISSION, CARDIOVASCULAR RISK FACTOR TARGET ATTAINMENT AND ANTIPHOSPHOLIPID SYNDROME

THU0260 Circulating levels of tnf-like cytokine 1A (TL1A) are increased in patients with ankylosing spondylitis

POS0172 ARTERIAL STIFFNESS IN ANTIPHOSPHOLIPID SYNDROME: COMPARISON WITH DIABETES MELLITUS AND HEALTHY CONTROLS

Microwave Radiometry for the Diagnosis and Monitoring of Inflammatory Arthritis

Suchergebnisse filtern